Several hundred perspectives on the questions facing payers, providers, biopharma, medtech, and digital health — plus our running read on the clinical literature. Start with our sharpest work, or filter to your world.
Recon authors analyze breast biopsy rates and market dynamics to reveal in an HA Scholar paper how provider environment shapes diagnostic practice
By
David Kaufmann
In the News
Read more
Biopharma Product Strategy: Lessons from Over- and Under-performing Launches
By
David Kaufmann
Biopharma
Read more
Trends in biotech deals in 2022 and 2023: oncology vs. the rest
By
David Kaufmann
Biopharma
Read more
Trends in oncolytic virus therapeutics: then and now